Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
NeoImmune Tech
Genexine
Roche
R&D
melanoma
Merkel cell carcinoma
cutaneous squamous cell carcinoma
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
Tue, 05/1/18 - 09:16 pm
NeoImmune Tech
Genexine
Roche
HyLeukin-7
checkpoint inhibitors
melanoma
Ocrevus fuels fast start to year for Roche
Biopharma Dive
Thu, 04/26/18 - 07:21 pm
Roche
earnings
Ocrevus
Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra
Endpoints
Thu, 04/26/18 - 11:11 am
Roche
hemophilia
Hemlibra
anti-drug antibodies
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Vertex Pharmaceuticals
Sanofi
earnings
FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin
CP Wire
Mon, 04/23/18 - 09:28 am
Pfizer
FDA
Roche
Herceptin
biosimilars
FDA Fails to Approve Pfizer's Biosimilar of Roche's Herceptin
Mon, 04/23/18 - 09:25 am
Pfizer
Herceptin
biosimilars
trastuzumab
Roche
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
CP Wire
Thu, 04/19/18 - 12:30 am
Roche
cobas EGFR Mutation Test
Tagrisso
non-small cell lung cancer
AstraZeneca
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
Thu, 04/19/18 - 12:13 am
Roche
Tagrisso
non-small cell lung cancer
Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing
Fierce Pharma
Tue, 04/17/18 - 11:33 am
Roche
Hemlibra
hemophilia
FDA
breakthrough status
ICER
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
Roche halts enrollment in a PhII combo study of Tecentriq and Cotellic in wake of several patient deaths
Endpoints
Wed, 04/11/18 - 11:02 am
Roche
Tecentriq
clinical trials
colon cancer
Exelixis
Cotellic
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Incyte
Merck
epacadostat
IDO inhibitors
Roche
NewLink Genetics
Roche Acquires MS Remyelination Program from Versant Ventures
CP Wire
Wed, 04/4/18 - 08:52 am
Roche
MS
multiple sclerosis
remylination
M&A
Versant Ventures
Inception 5
Roche Acquires MS Remyelination Program from Versant Ventures
Wed, 04/4/18 - 08:50 am
Roche
Versant Ventures
multiple sclerosis
Under fire for 5 deaths of patients taking Hemlibra, Roche spills details
Fierce Pharma
Fri, 03/30/18 - 05:56 pm
Hemlibra
Roche
hemophilia
Hemophilia groups warned of 5 deaths among patients taking Roche’s big new blockbuster Hemlibra
Endpoints
Tue, 03/27/18 - 10:13 pm
hemophilia
Roche
Hemlibra
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Mon, 03/26/18 - 10:37 pm
Roche
Avastin
Tecentriq
lung cancer
Roche's Tecentriq cocktail notches another lung cancer success
Yahoo/Reuters
Mon, 03/26/18 - 09:38 am
Roche
Tecentriq
lung cancer
clinical trials
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Mon, 03/26/18 - 09:36 am
Amgen
Allergan
Herceptin
biosimilars
ABP 980
CHMP
EMA
Roche
Pages
« first
‹ previous
…
46
47
48
49
50
51
52
53
54
…
next ›
last »